JEF News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

JE

Mkt Cap

$10.29B

Volume

2.09M

Loading chart

JE

JEFJefferies Financial Group Inc.

JEF

Pay with—

Available Balance0.00

JE

Mkt Cap

$10.29B

Volume

2.09M

Next Earnings

N/A

Chart Financials Earnings News About Dividends Insider Filings

Does Paul Tudor Jones Know Something Wall Street Doesn't? The Billionaire Says It's 1999 All Over and That 2027 Is Going to Be 'Really, Really Challenging' for the Market.Billionaire hedge fund manager Paul Tudor Jones warns that the current market resembles 1999 before the dot-com bubble burst, predicting 2027 will be 'really, really challenging' for stocks. While most Wall Street strategists remain optimistic with price targets around 8,700-9,000 for the S&P 500, Jones cites negative investment flows and a 'two-speed economy' driven by AI adoption as key concerns. He notes the worst flow picture for U.S. stocks since 2002, driven by IPO unlocks and secondary offerings overwhelming corporate support from buybacks and M&A.The Motley Fool · Oct 15, 2026

Optimum Strategic Communications and Catalyst Advisors launch the official Networking Event Guide around the Jefferies Global Healthcare ConferenceOptimum Strategic Communications and Catalyst Advisors have launched an official Networking Event Guide to help attendees navigate events around the Jefferies Global Healthcare Conference and London Life Sciences Week (15-20 November 2026). The guide consolidates receptions, investor gatherings, and networking opportunities across London. The two firms will also host a London Landmarks 5K Run on 17 November to facilitate networking among life sciences leaders, investors, and founders.GlobeNewswire Inc. · Oct 13, 2026

Star Bulk Carriers Corp. Announces Renewal of Existing ATM Equity Offering ProgramsStar Bulk Carriers Corp. announced the renewal of its existing At-The-Market (ATM) equity offering programs with Deutsche Bank Securities Inc. and Jefferies LLC. The renewal follows the expiration of the previous shelf registration statement and does not expand the existing programs, with available capacity of $41.4 million and $75 million respectively. The company maintains a fleet of 138 vessels with 13.8 million deadweight tonnage capacity.GlobeNewswire Inc. · Oct 9, 2026

Can Jefferies' Expanded SMBC Partnership Bolster Its Growth in Japan?Jefferies Financial Group is launching a Japan-based joint venture with Sumitomo Mitsui Banking Corporation (SMBC) expected to begin operations in January 2027. SMBC has increased its equity stake in Jefferies to nearly 20%, becoming the largest shareholder. The JV will combine SMBC's domestic Japanese client relationships and equities capabilities with Jefferies' global investment banking network, targeting institutional equities and ECM opportunities. Early results show M&A and ECM market share for jointly covered sponsor clients increased more than fourfold since 2024.Zacks Investment Research · Oct 2, 2026

Jefferies' Q3 IB, Equities Offset Weak Asset Management & Fixed IncomeJefferies Financial Group reported mixed Q3 fiscal 2026 results with record Investment Banking (up 17%) and Equities (up 29%) revenues reaching $1.33B and $626.2M respectively, offsetting significant weakness in Asset Management (down 52%) and Fixed Income (down 26%). Net revenues rose 9% YoY to $2.22B with net earnings increasing to $260.6M. The company's earnings growth sustainability depends on continued strength in deal-making and equities activity alongside improvement in weaker business segments.Zacks Investment Research · Sep 30, 2026

What Does Jefferies' Q3 Result Say About Wall Street's IB Recovery?Jefferies Financial Group reported record third-quarter investment banking revenues of $1.33B, up 17% year-over-year, with advisory revenues climbing 25% and equity underwriting surging 69%. The strong results suggest a healthy M&A backdrop and deal pipeline, though upcoming earnings from major banks are expected to show varied performance depending on their exposure to different banking segments.Zacks Investment Research · Sep 30, 2026

Gear Up for Jefferies (JEF) Q3 Earnings: Wall Street Estimates for Key MetricsJefferies is expected to report Q3 earnings of $1.04 per share, down 1% year-over-year, with revenues forecast at $2.21 billion, up 8.1%. EPS estimates have been revised 8.1% higher over the last 30 days. Key metrics show mixed performance: Asset Management revenues declining 35.6%, while Investment Banking and Capital Markets revenues growing 12.7%. Equity underwriting is projected to surge 74%, though debt underwriting is expected to fall 29.9%. The stock has declined 9.7% in the past month and carries a Zacks Rank #3 (Hold) rating.Zacks Investment Research · Sep 23, 2026

Kinzey Capital Management: Electra Sets Nasdaq IPO TermsElectra Therapeutics is pricing 21.7 million shares at $14-$16 each on Nasdaq under ticker ETRA, targeting up to $347 million to advance ipsoprubart through its SURPASS registration trial for secondary haemophagocytic lymphohistiocytosis. The offering values the clinical-stage antibody developer near $1 billion, with frontline data showing 100% overall survival at eight weeks versus historical 20-30% mortality rates.GlobeNewswire Inc. · Sep 19, 2026

Anthropic IPO: 1 Key Lesson Investors Can Learn From SpaceXSpaceX's IPO experienced significant volatility after investors grew concerned about the company's massive AI spending ($28.5B capex with 86% going to AI infrastructure) despite modest revenue ($12.5B). Historical data shows large IPOs average only 3.5% returns over 12 months despite strong first-week gains. The article warns that Anthropic's upcoming IPO could face similar investor skepticism regarding heavy AI infrastructure spending, suggesting investors should wait rather than buy at IPO launch.The Motley Fool · Sep 19, 2026

Why TJX Companies Stock Got Thrashed in AugustTJX Companies' stock dropped nearly 15% in August despite solid Q2 2027 earnings with 5% revenue growth and 22% net income increase. The decline was driven by the company's full-year adjusted earnings guidance of $5.15-$5.20 per share falling short of analyst expectations of $5.22, combined with downgrades from Jefferies and Gordon Haskett analysts. The stock's prior strong performance had inflated valuations, making investors unforgiving of even modest misses on forward guidance.The Motley Fool · Sep 4, 2026

to start trading

JE

JEFJefferies Financial Group Inc.

JEF

Pay with—

Available Balance0.00

Your PositionYou don't own any JEF yet.

Related Tickers

Earnings

Dividends

Ex Nov 16

Amount$0.40

PaysNov 25

Last · Aug 18Quarterly

Amount$0.40

Yield3.57%

Annual$1.60